Table 1 Basic characteristics of the study sample after 1:1 matching
Variable | Proportion affected among patients with NAFLD (%) N = 92,225 | Proportion affected among patients without NAFLD (%) N = 92,225 | p-value |
|---|---|---|---|
Age (mean, SD) | 57.4 (14.2) | 57.4 (14.3) | 0.905 |
Age 18–50 | 30.4 | 30.4 | 0.826 |
Age 51–60 | 26.5 | 26.5 | |
Age 61–70 | 23.6 | 23.5 | |
Age > 70 | 19.5 | 19.6 | |
Women | 47.8 | 47.8 | 1.000 |
Men | 52.5 | 52.5 | |
Yearly consultation frequency (mean, SD) | 8.8 (6.5) | 8.8 (6.5) | 1.000 |
Diabetes | 27.1 | 27.1 | 1.000 |
Hypertension | 56.3 | 56.3 | 1.000 |
Drug classes prescribed within 12 months prior to the index date | |||
Insulin | 3.7 | 5.1 | < 0.001 |
Diuretics | 8.9 | 10.3 | < 0.001 |
Beta blockers | 20.4 | 22.8 | < 0.001 |
Calcium channel blockers | 10.4 | 10.9 | 0.002 |
ACE inhibitors | 18.4 | 20.9 | < 0.001 |
Angiotensin II receptor blockers | 13.5 | 13.0 | 0.008 |